First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany | ALK

First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany

Created date
Nasdaq ID
3105575
Last updated: 26.06.2025